Chimeric Antigen Receptor (CAR) T cell therapy is a revolutionary approach in the field of cancer immunotherapy.
Chimeric Antigen Receptor (CAR) T Cell Therapy


Chimeric Antigen Receptor (CAR) T cell therapy is a revolutionary approach in the field of cancer immunotherapy.
Inflammatory bowel disease (IBD), which affects millions of people worldwide, is made up of various conditions that cause chronic inflammation of the gastrointestinal (GI) tract. The two main conditions are ulcerative colitis and Crohn’s disease. Crohn’s disease can affect any

ProSci offers reagents that can be used to study the actions of multiple immune checkpoint proteins such as CTLA-4, PD-1, & its ligands PD-L1 & PD-L2.

To support research & studies into infectious diseases, ProSci has reagents for the study of many viral disease agents inc. Covid, HIV, & Influenza.

CycLex NAMPT Colorimetric Assay Kit detects nicotinamide phosphoribosyltransferase (NAMPT) activity in recombinant NAMPT or endogenous NAMPT immunoprecipitated from cell extract.

The Ab-Match series by MBL are innovative ELISA kits for the detection of cancer antigens. These convenient kits come with all the necessary components for successful detection.

Investigators have developed a gating strategy that effectively minimises non-specific staining by incorporating a dump channel.

Histone deacetylase (HDAC) plays a pivotal role in the regulation of gene expression through the modification of nucleosome structure.

As viruses create more of themselves, they mutate – single-point changes in genetic code. SARS-CoV-2 virus mutated to be more transmissible.

The cytokine storm is a relatively new discovery & is actively being studied. ProSci offers cytokine & chemokine antibodies & recombinant proteins.